MEDP as reported
Medpace Holdings, Inc. reported $2.78B of revenue over the trailing twelve months, +25% on the year before. 11 reported series are charted on this page, each one as filed.
$2.78B
Revenue, trailing twelve months · to Q2 2026 · +25% against the twelve months before
- Net Income
- $492M
Net Income · +17% year on year · trailing twelve months to Q2 2026
- Free Cash Flow
- $707M
Free Cash Flow · +22% year on year · trailing twelve months to Q2 2026
- Op Margin
- 21%
Op Margin · trailing twelve months to Q2 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $2.78B | +25% | Q2 2026 |
| Net Income | $492M | +17% | Q2 2026 |
| EPS | $17.03 | +27% | Q2 2026 |
| Gross Margin | 29% | n/a | Q2 2026 |
| Op Margin | 21% | n/a | Q2 2026 |
| Net Margin | 18% | n/a | Q2 2026 |
| ROE | 109% | n/a | Q2 2026 |
| ROA | 23% | n/a | Q2 2026 |
| ROIC | 68% | n/a | Q4 2023 · 10 quarters behind |
| Free Cash Flow | $707M | +22% | Q2 2026 |
| P/E | 36.4 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Medpace Holdings, Inc. (MEDP) - Revenue & ProfitRevenue & ProfitMedpace Holdings, Inc. (MEDP)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Diagnostics & Research
Ranks #3 of 29 by Smart Score